1Ubaldi FM,Rienzi L,Ferrero S,et al.Management of poor responders in IVF[J].Reprod Biomed Online,2005,10:235-246.
2Muasher SJ.Controversies in assisted reproduction:treatment of low re-sponders[J].J Assisted Reprod Genet,1993,10(1):112-114.
3Watt AH,Legedza AT,Ginsburg ES,et al.The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization[J]J Assist Reprod Genet,2000,17(5):264.
5Ferraretti Ap,La Marca A,Fauser BC,et al.ESHRE working group on poor Ovarian Response Definition.ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization:the Bologna criteria[J].Hum Reprod,2011,26 (7):1616-1624.
6Scott RT Jr,Elkind-Hirsch KE,Styne-Gross A.The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimula-ting hormone[J].Fertil Steril,2008,89 (3):868-878.
7Kimberly E.Liu,M.D.,and Ellen M.Greenblatt,M.D.Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio R 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles[J].Fertil Steril,2008,90 (1):297-301.
8Roberts JE,Spandorfer S,Fasouliotis SJ,et al.Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization[J].Fertil Steril,2005,83(1):37-41.
9Fanchin R,Taieb J,Lozano DH,et al.High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secre-tion and strengthens its role in the assessment of ovarian follicular status[J].Hum Reprod,2005,20:923-927.
10Evers JL,Slants P,Land JA,et al.Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of fol-licle-stimulating hormone undergoing in vitro fertilization[J].Fertil Steril,1998,69(4):1010-1014.
5Dzik A, Lambert-Messerlian G, lzzo VM, et al. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle.Fertil Steril, 2000, 74(6):1 114-7.
6Joana P, Juan B, Francisco F, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod, 2000, 15(7):1499-504.
7Urbancsek J, Hauzman E & Klinga K. Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil Steril, 2005, 83(2):341-8.
8Welt CK, McNicholl D J, Taylor AE, et al. Female reproductive aging is marked by decreased secretion of dimeric inhibin.J Clin Endocrinol Metab, 1999, 84:105-11.
9Seller DB, Lambert-Messerlian G, Hogan JW, et al. Day 3serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril, 1997, 67(1):110-14.
10Satoko S, Masataka K, Shinichiro W, et al. Genetic and func- tional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod, 2002, 8(10):893-9.
6LAMAZOU F,FUCHS F,GRYBERG M,et al.Cancellation of IVF-ET cycles:poor prognosis,poor responder,or variability of the response to controlled ovarian hyperstimulation An analysis of 142 cancellations[J].Gynecol Obstet Biol Reprod(Paris),2012,41(1):41-47.
7SPREMOVI-RADJENOVI S,BILA J,GUDOVI A,et al.Poor Ovarian Response to Stimulation for In Vitro Fertilization[J].Srp Arh Celok Lek,2015,143(5-6):354-61.
